News

Duke University and Jubilant Organosys, through its subsidiary, Jubilant Biosys, have signed a Letter of Intent to develop a multi-faceted partnership that will expedite translation of discoveries by

Opko Health has completed the acquisition of rolapitant and a related compound from Schering Corporation, a subsidiary of Merck & Co (Schering). Rolapitant, a neurokinin-1 (NK-1) receptor antagonist,

Vivakor has completed a distribution agreement with consumer product specialist, Regeneca International for one of its proprietary, nutraceutical formulations. In conjunction with this agreement was an immediate purchase

Nuvo Research’s German subsidiary Dimethaid has entered into a new licensing agreement with Ranbaxy for Oxoferin. The company has also reported an additional funding assistance, which willbe provided

Natural Alternatives International (NAI) has filed a lawsuit in the US District Court for the District of Delaware, accusing Vital Pharmaceutical (VPX) and DNP International of infringing patents

Curtis Packaging was recognised as a green power by EPA, for a new purchase supports clean renewable resources. The company reportedly uses 6 million kilowatt-hours of green power

Camstar Systems has reported that Pacific Biosciences has selected the Camstar manufacturing enterprise software platform to enable its critical transition from product development to high-volume production. The company

Dow has announced the launch of low aldehyde grades of Carbowax Sentry PEG. The product is a niche product used to enhance shelf life of formulators. It was

ACADIA Pharmaceuticals reported an increase in revenue to $2.4m for the third quarter of 2009 from $282,000 for the third quarter of 2008. For the nine month ended